BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, Tang CM, Kang W, Lung RW, Li JW, Chan TF, Xing R, Lu Y, Lo KW, Wong N, To KF, Yu C, Chan FK, Sung JJ, Yu J. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 2014;147:1350-62.e4. [PMID: 25173755 DOI: 10.1053/j.gastro.2014.08.036] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Wang YC, Liu CJ. Application of single-cell transcriptome sequencing in gastric cancer. Shijie Huaren Xiaohua Zazhi 2023; 31(2): 48-55 [DOI: 10.11569/wcjd.v31.i2.48] [Reference Citation Analysis]
2 Rihane FE, Erguibi D, Chehab F, Ennaji MM. Hypermethylation of tumor suppressor genes associated with Helicobacter pylori and Epstein–Barr virus infections in gastric cancer. Oncogenic Viruses 2023. [DOI: 10.1016/b978-0-12-824152-3.00009-3] [Reference Citation Analysis]
3 Agnarelli A, Vella V, Samuels M, Papanastasopoulos P, Giamas G. Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers 2022;14:4378. [DOI: 10.3390/cancers14184378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang L, Wang R, Xie Z. The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol. [DOI: 10.1007/s00253-022-12029-3] [Reference Citation Analysis]
5 Leibold J, Amor C, Tsanov KM, Ho Y, Sánchez-rivera FJ, Feucht J, Baslan T, Chen H, Tian S, Simon J, Wuest A, Wilkinson JE, Lowe SW. Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease.. [DOI: 10.1101/2022.06.15.494941] [Reference Citation Analysis]
6 Wang X, Zhang L, Chan FKL, Ji J, Yu J, Liang JQ. Gamma-glutamyltransferase 7 suppresses gastric cancer by cooperating with RAB7 to induce mitophagy. Oncogene 2022. [PMID: 35662282 DOI: 10.1038/s41388-022-02339-1] [Reference Citation Analysis]
7 Li C, Zhang L, Qiu Z, Deng W, Wang W. Key Molecules of Fatty Acid Metabolism in Gastric Cancer. Biomolecules 2022;12:706. [DOI: 10.3390/biom12050706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Firoz A, Ali HM, Rehman S, Rather IA. Gastric Cancer and Viruses: A Fine Line between Friend or Foe. Vaccines 2022;10:600. [DOI: 10.3390/vaccines10040600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhou Y, Huang J, Jin B, He S, Dang Y, Zhao T, Jin Z. The Emerging Role of Hedgehog Signaling in Viral Infections. Front Microbiol 2022;13:870316. [DOI: 10.3389/fmicb.2022.870316] [Reference Citation Analysis]
10 Cao Z, Zeng L, Feng L, Feng X. Comprehensive analysis of the differential cellular and EBV miRNA expression profiles in Mature T and NK cell lymphomas. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153846] [Reference Citation Analysis]
11 Chakravorty S, Afzali B, Kazemian M. EBV-associated diseases: Current therapeutics and emerging technologies. Front Immunol 2022;13:1059133. [PMID: 36389670 DOI: 10.3389/fimmu.2022.1059133] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Syed IB, Nannapaneni M. Estimation of Olanzapine and Samidorphan in bulk and Pharmaceutical Dosage Form Using RP-HPL. Int J Pharm Res Allied Sci 2022;11:87-94. [DOI: 10.51847/zqd8wfwa6y] [Reference Citation Analysis]
13 Huang JT, Chen JN, Bi YH, Gong LP, Zhang JY, DU Y, Shao CK. Comparative Transcriptome Provides a Systematic Perspective on Epstein-Barr Virus-Associated Gastric Carcinoma Cell Lines. Onco Targets Ther 2021;14:5169-82. [PMID: 34720592 DOI: 10.2147/OTT.S332513] [Reference Citation Analysis]
14 Marongiu L, Allgayer H. Viruses in colorectal cancer. Mol Oncol 2021. [PMID: 34514694 DOI: 10.1002/1878-0261.13100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wang H, Chen XL, Liu K, Bai D, Zhang WH, Chen XZ, Hu JK; SIGES research group. Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies.Clin Transl Gastroenterol. 2020;11:e00201. [PMID: 32764207 DOI: 10.14309/ctg.0000000000000201] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
16 Chen ZH, Yan SM, Chen XX, Zhang Q, Liu SX, Liu Y, Luo YL, Zhang C, Xu M, Zhao YF, Huang LY, Liu BL, Xia TL, Xu DZ, Liang Y, Chen YM, Wang W, Yuan SQ, Zhang HZ, Yun JP, Zhai WW, Zeng MS, Bai F, Zhong Q. The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma. Genome Med 2021;13:146. [PMID: 34493320 DOI: 10.1186/s13073-021-00963-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Cao M, Zhang C, Zhou L. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma. Epigenomics 2021. [PMID: 34369810 DOI: 10.2217/epi-2021-0118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rihane FE, Erguibi D, Elyamine O, Abumsimir B, Ennaji MM, Chehab F. Helicobacter pylori co-infection with Epstein-Barr virus and the risk of developing gastric adenocarcinoma at an early age: Observational study infectious agents and cancer. Ann Med Surg (Lond) 2021;68:102651. [PMID: 34386233 DOI: 10.1016/j.amsu.2021.102651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Frappier L. Epstein-Barr virus: Current questions and challenges. Tumour Virus Res 2021;12:200218. [PMID: 34052467 DOI: 10.1016/j.tvr.2021.200218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Tanabe H, Mizukami Y, Takei H, Tamamura N, Omura Y, Kobayashi Y, Murakami Y, Kunogi T, Sasaki T, Takahashi K, Ando K, Ueno N, Kashima S, Yuzawa S, Hasegawa K, Sumi Y, Tanino M, Fujiya M, Okumura T. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria. J Pathol Clin Res 2021;7:397-409. [PMID: 33750036 DOI: 10.1002/cjp2.209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X, Wu J, Liu B, Ying X, Liu Y. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut 2021;70:464-75. [PMID: 32532891 DOI: 10.1136/gutjnl-2019-320368] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 42.5] [Reference Citation Analysis]
22 Wu D, Jia H, Zhang Z, Li S. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Bioorg Chem 2021;109:104722. [PMID: 33618253 DOI: 10.1016/j.bioorg.2021.104722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
23 Zhu M, Liang Q, Chen T, Kong Q, Ye G, Yu S, Li X, He Q, Liu H, Hu Y, Yu J, Li G. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer. Clin Epigenetics 2021;13:22. [PMID: 33514440 DOI: 10.1186/s13148-020-00989-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Alsofyani AA, Dallol A, Farraj SA, Alsiary RA, Samkari A, Alhaj-Hussain BT, Khan JA, Al-Maghrabi J, Al-Khayyat SS, Alkhatabi H, Elaimi A, Buhmeida A, Johargy AK, Abuzenadah AM, Azhar EI, Al-Qahtani MH. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes. Cancer Biomark 2020;28:213-20. [PMID: 32250288 DOI: 10.3233/CBM-190897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Li W, Okabe A, Kaneda A. Epigenetic aberrations by Epstein–Barr virus infection to develop gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00006-x] [Reference Citation Analysis]
26 Sun K, Jia K, Lv H, Wang SQ, Wu Y, Lei H, Chen X. EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives. Front Oncol 2020;10:583463. [PMID: 33381453 DOI: 10.3389/fonc.2020.583463] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
27 Hatayama Y, Hashimoto Y, Motokura T. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy. J Int Med Res 2020;48:300060520972880. [PMID: 33249964 DOI: 10.1177/0300060520972880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Tao ZH, Han JX, Fang JY. Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota. Helicobacter 2020;25:e12754. [PMID: 32876377 DOI: 10.1111/hel.12754] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
29 Stanland LJ, Luftig MA. The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis. Viruses 2020;12:E1222. [PMID: 33126718 DOI: 10.3390/v12111222] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
30 Fan X, Li Y, Yi X, Chen G, Jin S, Dai Y, Cui B, Dai B, Lin H, Zhou D. Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients. Neoplasia 2020;22:630-43. [PMID: 33059309 DOI: 10.1016/j.neo.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Geng Q, Lao J, Zuo X, Chen S, Bei JX, Xu D. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes. J Pathol 2020;252:263-73. [PMID: 32715475 DOI: 10.1002/path.5516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yang J, Liu Z, Zeng B, Hu G, Gan R. Epstein-Barr virus-associated gastric cancer: A distinct subtype. Cancer Lett 2020;495:191-9. [PMID: 32979463 DOI: 10.1016/j.canlet.2020.09.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
33 Fiches GN, Zhou D, Kong W, Biswas A, Ahmed EH, Baiocchi RA, Zhu J, Santoso N. Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses. PLoS Pathog 2020;16:e1008778. [PMID: 32841292 DOI: 10.1371/journal.ppat.1008778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
34 Wu CW, Chen MH, Huang KH, Chang SC, Fang WL, Lin CH, Chao Y, Lo SS, Li AF, Shyr YM. The clinicopathological characteristics and genetic alterations between younger and older gastric cancer patients with curative surgery. Aging (Albany NY) 2020;12:18137-50. [PMID: 32961530 DOI: 10.18632/aging.103627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Mikhaleva LM, Akopyan EP, Midiber KY, Vasyukova OA. Mixed-type gastric carcinoma: classification, morphological diagnosis and prognosis of the disease. jour 2020;98:197-202. [DOI: 10.30629/0023-2149-2020-98-3-197-202] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Song Y, Li Q, Liao S, Zhong K, Jin Y, Zeng T. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer. Virology 2020;548:6-16. [PMID: 32530809 DOI: 10.1016/j.virol.2020.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
37 Zhao Y, Zhang J, Cheng ASL, Yu J, To KF, Kang W. Gastric cancer: genome damaged by bugs. Oncogene 2020;39:3427-42. [PMID: 32123313 DOI: 10.1038/s41388-020-1241-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
38 Liu W, Luo B. The impact of EBV on the epigenetics of gastric carcinoma. Future Virology 2020;15:183-93. [DOI: 10.2217/fvl-2019-0148] [Reference Citation Analysis]
39 Jing JJ, Li H, Wang ZY, Zhou H, Sun LP, Yuan Y. Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer. Future Oncol 2020;16:187-97. [PMID: 31989840 DOI: 10.2217/fon-2019-0649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Movassagh M, Oduor C, Forconi C, Moormann AM, Bailey JA. Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia. Sci Rep 2019;9:20321. [PMID: 31889055 DOI: 10.1038/s41598-019-56472-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
41 Thun GA, Derdak S, Castro-Giner F, Apunte-Ramos K, Águeda L, Wjst M, Boland A, Deleuze JF, Kolsum U, Heiss-Neumann MS, Nowinski A, Gorecka D, Hohlfeld JM, Welte T, Brightling CE, Parr DG, Prasse A, Müller-Quernheim J, Greulich T, Stendardo M, Boschetto P, Barta I, Döme B, Gut M, Singh D, Ziegler-Heitbrock L, Gut IG. High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controls. Sci Rep 2019;9:20158. [PMID: 31882973 DOI: 10.1038/s41598-019-56618-1] [Reference Citation Analysis]
42 Danilova NV, Malkov PG, Oleynikova NA, Mikhailov IA. [Epstein-Barr virus-associated gastric adenocarcinoma]. Arkh Patol 2019;81:74-83. [PMID: 31317934 DOI: 10.17116/patol20198103174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Liu J, Li S, Chen S, Chen S, Geng Q, Xu D. c‐Met‐dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis. J Pathol 2019;249:126-36. [DOI: 10.1002/path.5287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
44 Wang Y, Wang K, Jin Y, Sheng X. Endoplasmic reticulum proteostasis control and gastric cancer. Cancer Lett 2019;449:263-71. [PMID: 30776479 DOI: 10.1016/j.canlet.2019.01.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
45 Del Moral-Hernández O, Castañón-Sánchez CA, Reyes-Navarrete S, Martínez-Carrillo DN, Betancourt-Linares R, Jiménez-Wences H, de la Peña S, Román-Román A, Hernández-Sotelo D, Fernández-Tilapa G. Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study. Medicine (Baltimore) 2019;98:e14124. [PMID: 30653141 DOI: 10.1097/MD.0000000000014124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
46 de Souza CRT, Almeida MCA, Khayat AS, da Silva EL, Soares PC, Chaves LC, Burbano RMR. Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas. World J Gastroenterol 2018; 24(43): 4928-4938 [PMID: 30487702 DOI: 10.3748/wjg.v24.i43.4928] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
47 Liang JQ, Teoh N, Xu L, Pok S, Li X, Chu ESH, Chiu J, Dong L, Arfianti E, Haigh WG, Yeh MM, Ioannou GN, Sung JJY, Farrell G, Yu J. Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling. Nat Commun. 2018;9:4490. [PMID: 30367044 DOI: 10.1038/s41467-018-06931-6] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
48 Velapasamy S, Dawson CW, Young LS, Paterson IC, Yap LF. The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers. Cancers (Basel) 2018;10:E247. [PMID: 30060514 DOI: 10.3390/cancers10080247] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
49 Li L, Ma BBY, Chan ATC, Chan FKL, Murray P, Tao Q. Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas. Pathogens 2018;7:E63. [PMID: 30022006 DOI: 10.3390/pathogens7030063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
50 Kosova IV, Loran OB, Sinyakova LA, Gundorova LV, Kosov VA, Pogodina IE, Kolbasov DM. Immunohistochemical characteristics of bladder cancer in patients with virus-positive tumors. Cancer Urology 2018;14:142-154. [DOI: 10.17650/1726-9776-2018-14-2-142-154] [Reference Citation Analysis]
51 Ho TH, Sitz J, Shen Q, Leblanc-Lacroix A, Campos EI, Borozan I, Marcon E, Greenblatt J, Fradet-Turcotte A, Jin DY, Frappier L. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein. J Virol 2018;92:e00262-18. [PMID: 29743367 DOI: 10.1128/JVI.00262-18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
52 Wong CC, Li W, Chan B, Yu J. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Semin Cancer Biol 2019;55:90-105. [PMID: 29665409 DOI: 10.1016/j.semcancer.2018.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
53 Namikawa T, Fujisawa K, Munekage E, Munekage M, Oki Y, Maeda H, Kitagawa H, Ueta H, Kobayashi M, Hanazaki K. Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma, accompanied with lymph node metastasis. Mol Clin Oncol 2018;8:557-60. [PMID: 29541465 DOI: 10.3892/mco.2018.1567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Baek SJ, Kim M, Bae DH, Kim JH, Kim HJ, Han ME, Oh SO, Kim YS, Kim SY. Integrated epigenomic analyses of enhancer as well as promoter regions in gastric cancer. Oncotarget 2016;7:25620-31. [PMID: 27016420 DOI: 10.18632/oncotarget.8239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
55 Zhang X, Yang W, Wang J, Meng Y, Guan Y, Yang J. FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes. Metabolism 2018;81:71-82. [PMID: 29221790 DOI: 10.1016/j.metabol.2017.12.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
56 Yao Y, Xu M, Liang L, Zhang H, Xu R, Feng Q, Feng L, Luo B, Zeng YX. Genome-wide analysis of Epstein-Barr virus identifies variants and genes associated with gastric carcinoma and population structure. Tumour Biol 2017;39:1010428317714195. [PMID: 29034771 DOI: 10.1177/1010428317714195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
57 Wang C, Zou J, Ma X, Wang E, Peng G. Mechanisms and implications of ADAR-mediated RNA editing in cancer. Cancer Lett 2017;411:27-34. [PMID: 28974449 DOI: 10.1016/j.canlet.2017.09.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
58 Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, Oshima M, Iwama A, Fukayama M, Kaneda A. Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus. Sci Rep 2017;7:7924. [PMID: 28801683 DOI: 10.1038/s41598-017-08370-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
59 Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang Y, Zhou J, Pan K, Sun L, Fang J, Yuan Y, You W, Fan D. A global burden of gastric cancer: the major impact of China. Expert Rev Gastroenterol Hepatol 2017;11:651-61. [PMID: 28351219 DOI: 10.1080/17474124.2017.1312342] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 9.7] [Reference Citation Analysis]
60 Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers 2017;3:17036. [PMID: 28569272 DOI: 10.1038/nrdp.2017.36] [Cited by in Crossref: 292] [Cited by in F6Publishing: 308] [Article Influence: 48.7] [Reference Citation Analysis]
61 Ma J, Li J, Hao Y, Nie Y, Li Z, Qian M, Liang Q, Yu J, Zeng M, Wu K. Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy. Oncotarget. 2017;8:67094-67103. [PMID: 28978018 DOI: 10.18632/oncotarget.17945] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
62 Song Y, Wang Y, Tong C, Xi H, Zhao X, Wang Y, Chen L. A unified model of the hierarchical and stochastic theories of gastric cancer. Br J Cancer 2017;116:973-89. [PMID: 28301871 DOI: 10.1038/bjc.2017.54] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
63 Liu X, Meltzer SJ. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol 2017;3:348-58. [PMID: 28462377 DOI: 10.1016/j.jcmgh.2017.02.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
64 Yang XW, Gao F, Chen YJ, Teng FM. The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer. Cell Biochem Biophys. 2015;72:649-652. [PMID: 27352182 DOI: 10.1007/s12013-014-0356-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
65 Birdwell CE, Queen K, Scott RS. Epigenetic Consequences of Epstein–Barr Virus Infection. Epigenetics of Infectious Diseases 2017. [DOI: 10.1007/978-3-319-55021-3_4] [Reference Citation Analysis]
66 Jácome AA, Lima EM, Kazzi AI, Chaves GF, Mendonça DC, Maciel MM, Santos JS. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease? Rev Soc Bras Med Trop. 2016;49:150-157. [PMID: 27192582 DOI: 10.1590/0037-8682-0270-2015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
67 Tie J, Zhang X, Fan D. Epigenetic roles in the malignant transformation of gastric mucosal cells. Cell Mol Life Sci 2016;73:4599-610. [PMID: 27464701 DOI: 10.1007/s00018-016-2308-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
68 Yu J, Liang Q, Wang J, Wang K, Gao J, Zhang J, Zeng Y, Chiu PW, Ng EK, Sung JJ. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene 2017;36:182-93. [PMID: 27212034 DOI: 10.1038/onc.2016.187] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
69 Liu L, Cao L, Gong B, Yu J. Novel biomarkers for the identification and targeted therapy of gastric cancer. Expert Rev Gastroenterol Hepatol 2015;9:1217-26. [PMID: 26220043 DOI: 10.1586/17474124.2015.1072466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
70 Wu WK, Yu J, Chan MT, To KF, Cheng AS. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis. J Pathol 2016;239:245-9. [PMID: 27102722 DOI: 10.1002/path.4731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
71 Zhao R, Choi BY, Lee MH, Bode AM, Dong Z. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. EBioMedicine 2016;8:30-9. [PMID: 27428416 DOI: 10.1016/j.ebiom.2016.04.017] [Cited by in Crossref: 172] [Cited by in F6Publishing: 185] [Article Influence: 24.6] [Reference Citation Analysis]
72 Kanda T, Furuse Y, Oshitani H, Kiyono T. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains. J Virol. 2016;90:4383-4393. [PMID: 26889033 DOI: 10.1128/jvi.00060-16] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
73 Cofer ZC, Cui S, EauClaire SF, Kim C, Tobias JW, Hakonarson H, Loomes KM, Matthews RP. Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia. PLoS One 2016;11:e0151521. [PMID: 27010479 DOI: 10.1371/journal.pone.0151521] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
74 Giudice A, D'Arena G, Crispo A, Tecce MF, Nocerino F, Grimaldi M, Rotondo E, D'Ursi AM, Scrima M, Galdiero M. Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis. Oxid Med Cell Longev. 2016;2016:6021934. [PMID: 26977250 DOI: 10.1155/2016/6021934] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
75 Ernberg I, Niller HH, Minarovits J. Epigenetic Alterations of Viral and Cellular Genomes in EBV-Infected Cells. Epigenetics - A Different Way of Looking at Genetics 2016. [DOI: 10.1007/978-3-319-27186-6_6] [Reference Citation Analysis]
76 Lim H, Park YS, Lee JH, Son DH, Ahn JY, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Yook JH, Kim BS. Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus. Clin Gastroenterol Hepatol 2015;13:1738-1744.e2. [PMID: 25912839 DOI: 10.1016/j.cgh.2015.04.015] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
77 Tan P, Yeoh KG. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. Gastroenterology 2015;149:1153-1162.e3. [PMID: 26073375 DOI: 10.1053/j.gastro.2015.05.059] [Cited by in Crossref: 269] [Cited by in F6Publishing: 284] [Article Influence: 33.6] [Reference Citation Analysis]
78 Lin Y, Wu Z, Guo W, Li J. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies. Tumour Biol. 2015;36:7385-7394. [PMID: 26364057 DOI: 10.1007/s13277-015-4002-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
79 Figueiredo C, Costa S, Karameris A, Machado JC. Pathogenesis of Gastric Cancer. Helicobacter 2015;20 Suppl 1:30-5. [PMID: 26372822 DOI: 10.1111/hel.12254] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
80 Liu Y, Zhang X, Zhang Y, Hu Z, Yang D, Wang C, Guo M, Cai Q. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer. Cancer Lett 2015;369:58-66. [PMID: 26276722 DOI: 10.1016/j.canlet.2015.06.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
81 Gulley ML. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. Exp Mol Med. 2015;47:e134. [PMID: 25613731 DOI: 10.1038/emm.2014.93] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
82 Houldcroft CJ, Kellam P. Host genetics of Epstein-Barr virus infection, latency and disease. Rev Med Virol. 2015;25:71-84. [PMID: 25430668 DOI: 10.1002/rmv.1816] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]